{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:37:27Z","timestamp":1790818647390,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Institut de Recherche en Sant\u00e9 Publique","award":["17-PREV-49"],"award-info":[{"award-number":["17-PREV-49"]}]},{"DOI":"10.13039\/501100007543","name":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des Produits de Sant\u00e9","doi-asserted-by":"publisher","award":["AAP-2014-033"],"award-info":[{"award-number":["AAP-2014-033"]}],"id":[{"id":"10.13039\/501100007543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s40264-020-00916-5","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T16:03:02Z","timestamp":1583164982000},"page":"549-559","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Identifying Drugs Inducing Prematurity by Mining Claims Data with High-Dimensional Confounder Score Strategies"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1711-236X","authenticated-orcid":false,"given":"Romain","family":"Demailly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0864-4321","authenticated-orcid":false,"given":"Sylvie","family":"Escolano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Haramburu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Tubert-Bitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0468-6858","authenticated-orcid":false,"given":"Isma\u00efl","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,2]]},"reference":[{"key":"916_CR1","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/pds.2184","volume":"20","author":"JR Daw","year":"2011","unstructured":"Daw JR, Hanley GE, Greyson DL, Morgan SG. Prescription drug use during pregnancy in developed countries: a systematic review. Pharmacoepidemiol Drug Saf. 2011;20:895\u2013902.","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"916_CR2","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1002\/pds.4265","volume":"26","author":"R Demailly","year":"2017","unstructured":"Demailly R, Escolano S, Quantin C, Tubert-Bitter P, Ahmed I. Prescription drug use during pregnancy in France: a study from the national health insurance permanent sample. Pharmacoepidemiol Drug Saf. 2017;26:1126\u201334.","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"916_CR3","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1053\/j.semperi.2015.08.002","volume":"39","author":"M Ayad","year":"2015","unstructured":"Ayad M, Costantine MM. Epidemiology of medications use in pregnancy. Semin Perinatol. 2015;39:508\u201311.","journal-title":"Semin Perinatol."},{"key":"916_CR4","doi-asserted-by":"publisher","first-page":"e017248","DOI":"10.1136\/bmjopen-2017-017248","volume":"7","author":"AA Veroniki","year":"2017","unstructured":"Veroniki AA, Rios P, Cogo E, Straus SE, Finkelstein Y, Kealey R, et al. Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis. BMJ Open. 2017;7:e017248.","journal-title":"BMJ Open."},{"key":"916_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ando.2015.03.008","volume":"76","author":"P F\u00e9nichel","year":"2015","unstructured":"F\u00e9nichel P, Brucker-Davis F, Chevalier N. The history of Distilb\u00e8ne\u00ae (diethylstilbestrol) told to grandchildren: the transgenerational effect. Ann Endocrinol (Paris). 2015;76:253\u20139.","journal-title":"Ann Endocrinol (Paris)"},{"key":"916_CR6","doi-asserted-by":"publisher","first-page":"e004365","DOI":"10.1136\/bmjopen-2013-004365","volume":"4","author":"A Lupattelli","year":"2014","unstructured":"Lupattelli A, Spigset O, Twigg MJ, Zagorodnikova K, M\u00e5rdby AC, Moretti ME, et al. Medication use in pregnancy: a cross-sectional, multinational web-based study. BMJ Open. 2014;4:e004365.","journal-title":"BMJ Open"},{"key":"916_CR7","doi-asserted-by":"publisher","first-page":"e1002160","DOI":"10.1371\/journal.pmed.1002160","volume":"13","author":"G Pariente","year":"2016","unstructured":"Pariente G, Leibson T, Carls A, Adams-Webber T, Ito S, Koren G. Pregnancy-associated changes in pharmacokinetics: a systematic review. PLoS Med. 2016;13:e1002160.","journal-title":"PLoS Med"},{"key":"916_CR8","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1053\/j.semperi.2015.08.003","volume":"39","author":"M Feghali","year":"2015","unstructured":"Feghali M, Venkataramanan R, Caritis S. Pharmacokinetics of drugs in pregnancy. Semin Perinatol. 2015;39:512\u20139.","journal-title":"Semin Perinatol"},{"key":"916_CR9","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/pds.4789","volume":"28","author":"KF Huybrechts","year":"2019","unstructured":"Huybrechts KF, Bateman BT, Hern\u00e1ndez-D\u00edaz S. Use of real-world evidence from healthcare utilization data to evaluate drug safety during pregnancy. Pharmacoepidemiol Drug Saf. 2019;28:906\u201322.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"916_CR10","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1177\/0962280216643116","volume":"27","author":"I Ahmed","year":"2018","unstructured":"Ahmed I, Pariente A, Tubert-Bitter P. Class-imbalanced subsampling lasso algorithm for discovering adverse drug reactions. Stat Methods Med Res. 2018;27:785\u201397.","journal-title":"Stat Methods Med Res"},{"key":"916_CR11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/sam.10078","volume":"3","author":"O Caster","year":"2010","unstructured":"Caster O, Nor\u00e9n GN, Madigan D, Bate A. Large-scale regression-based pattern discovery: the example of screening the WHO global drug safety database. Stat Anal Data Min ASA Data Sci J. 2010;3:197\u2013208.","journal-title":"Stat Anal Data Min ASA Data Sci J"},{"key":"916_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s40264-018-0766-8","volume":"42","author":"F Liu","year":"2019","unstructured":"Liu F, Jagannatha A, Yu H. Towards drug safety surveillance and pharmacovigilance: current progress in detecting medication and adverse drug events from electronic health records. Drug Saf. 2019;42:95\u20137.","journal-title":"Drug Saf"},{"key":"916_CR13","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/clpt.2012.50","volume":"91","author":"R Harpaz","year":"2012","unstructured":"Harpaz R, DuMouchel W, Shah NH, Madigan D, Ryan P, Friedman C. Novel data-mining methodologies for adverse drug event discovery and analysis. Clin Pharmacol Ther. 2012;91:1010\u201321.","journal-title":"Clin Pharmacol Ther"},{"key":"916_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s40264-018-0729-0","volume":"42","author":"A Kant","year":"2019","unstructured":"Kant A, de Vries L, Rolfes L. Surveillance of drug safety during pregnancy: insight in current international activities, future intentions and need for support of national pharmacovigilance centres. Drug Saf. 2019;42:35\u201343.","journal-title":"Drug Saf"},{"key":"916_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40471-017-0131-y","volume":"4","author":"JW Jackson","year":"2017","unstructured":"Jackson JW, Schmid I, Stuart EA. Propensity scores in pharmacoepidemiology: beyond the horizon. Curr Epidemiol Rep. 2017;4:271\u201380.","journal-title":"Curr Epidemiol Rep"},{"key":"916_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/0962280208092347","volume":"18","author":"PG Arbogast","year":"2009","unstructured":"Arbogast PG, Ray WA. Use of disease risk scores in pharmacoepidemiologic studies. Stat Methods Med Res. 2009;18:67\u201380.","journal-title":"Stat Methods Med Res"},{"key":"916_CR17","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/aje\/kwr143","volume":"174","author":"PG Arbogast","year":"2011","unstructured":"Arbogast PG, Ray WA. Performance of disease risk scores, propensity scores, and traditional multivariable outcome regression in the presence of multiple confounders. Am J Epidemiol. 2011;174:613\u201320.","journal-title":"Am J Epidemiol"},{"key":"916_CR18","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","volume":"20","author":"S Schneeweiss","year":"2009","unstructured":"Schneeweiss S, Rassen JA, Glynn RJ, Avorn J, Mogun H, Brookhart MA. High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology. 2009;20:512\u201322.","journal-title":"Epidemiology"},{"key":"916_CR19","doi-asserted-by":"publisher","first-page":"125ra31","DOI":"10.1126\/scitranslmed.3003377","volume":"4","author":"NP Tatonetti","year":"2012","unstructured":"Tatonetti NP, Ye PP, Daneshjou R, Altman RB. Data-driven prediction of drug effects and interactions. Sci Transl Med. 2012;4:125ra31.","journal-title":"Sci Transl Med"},{"key":"916_CR20","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.3389\/fphar.2018.01010","volume":"9","author":"\u00c9 Courtois","year":"2018","unstructured":"Courtois \u00c9, Pariente A, Salvo F, Volatier \u00c9, Tubert-Bitter P, Ahmed I. Propensity score-based approaches in high dimension for pharmacovigilance signal detection: an empirical comparison on the French Spontaneous Reporting Database. Front Pharmacol. 2018;9:1010.","journal-title":"Front Pharmacol"},{"key":"916_CR21","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.respe.2010.04.005","volume":"58","author":"P Tuppin","year":"2010","unstructured":"Tuppin P, de Roquefeuil L, Weill A, Ricordeau P, Merli\u00e8re Y. French national health insurance information system and the permanent beneficiaries sample. Rev Epidemiol Sante Publ. 2010;58:286\u201390.","journal-title":"Rev Epidemiol Sante Publ"},{"key":"916_CR22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jogoh.2018.05.014","volume":"47","author":"C Piffaretti","year":"2018","unstructured":"Piffaretti C, Looten V, Rey S, Fresson J, Fagot-Campagna A, Tuppin P. Management of pregnancy based on healthcare consumption of women who delivered in France in 2015: contribution of the national health data system (SNDS). J Gynecol Obstet Hum Reprod. 2018;47:299\u2013307.","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"916_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2458-9-33","volume":"9","author":"G Rey","year":"2009","unstructured":"Rey G, Jougla E, Fouillet A, H\u00e9mon D. Ecological association between a deprivation index and mortality in France over the period 1997\u20132001: variations with spatial scale, degree of urbanicity, age, gender and cause of death. BMC Public Health. 2009;9:33.","journal-title":"BMC Public Health"},{"key":"916_CR24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","volume":"58","author":"R Tibshirani","year":"1996","unstructured":"Tibshirani R. Regression shrinkage and selection via the Lasso. J R Stat Soc Ser B (Methodol). 1996;58:267\u201388.","journal-title":"J R Stat Soc Ser B (Methodol)"},{"key":"916_CR25","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1214\/aos\/1013203451","volume":"29","author":"J Friedman","year":"2001","unstructured":"Friedman J. Greedy boosting approximation: a gradient boosting machine. Ann Stat. 2001;29:1189\u2013232.","journal-title":"Ann Stat"},{"key":"916_CR26","doi-asserted-by":"crossref","unstructured":"Chen T, Guestrin C. XGBoost: a scalable tree boosting system. In: Proceedings of the 22nd ACM SIGKDD international conference on knowledge discovery and data mining-KDD \u201916; San Francisco (CA); 2016. pp 785\u201394.","DOI":"10.1145\/2939672.2939785"},{"key":"916_CR27","unstructured":"Zhang O. Winning data science competitions. NYC Data Science Academy. 2015.\u00a0https:\/\/nycdatascience.com\/blog\/meetup\/featured-talk-1-kaggle-data-scientist-owen-zhang\/. Accessed 1 Feb 2020."},{"key":"916_CR28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/0021-9681(66)90062-2","volume":"19","author":"ID Bross","year":"1966","unstructured":"Bross ID. Spurious effects from an extraneous variable. J Chronic Dis. 1966;19:637\u201347.","journal-title":"J Chronic Dis."},{"key":"916_CR29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1515\/ijb-2012-0030","volume":"9","author":"L Li","year":"2013","unstructured":"Li L, Greene T. A weighting analogue to pair matching in propensity score analysis. Int J Biostat. 2013;9:215\u201334.","journal-title":"Int J Biostat."},{"key":"916_CR30","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/pds.4336","volume":"27","author":"ME Wood","year":"2018","unstructured":"Wood ME, Lapane KL, van Gelder MMHJ, Rai D, Nordeng HME. Making fair comparisons in pregnancy medication safety studies: an overview of advanced methods for confounding control. Pharmacoepidemiol Drug Saf. 2018;27:140\u20137.","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"916_CR31","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1080\/02664763.2019.1582614","volume":"46","author":"C Ju","year":"2019","unstructured":"Ju C, Combs M, Lendle SD, Franklin JM, Wyss R, Schneeweiss S, et al. Propensity score prediction for electronic healthcare databases using super learner and high-dimensional propensity score methods. J Appl Stat. 2019;46:2216\u201336.","journal-title":"J Appl Stat."},{"key":"916_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/EDE.0000000000000762","volume":"29","author":"R Wyss","year":"2018","unstructured":"Wyss R, Schneeweiss S, van der Laan M, Lendle SD, Ju C, Franklin JM. Using super learner prediction modeling to improve high-dimensional propensity score estimation. Epidemiology. 2018;29:96\u2013106.","journal-title":"Epidemiology."},{"key":"916_CR33","doi-asserted-by":"publisher","first-page":"e12309","DOI":"10.1111\/appy.12309","volume":"10","author":"Y Ogawa","year":"2018","unstructured":"Ogawa Y, Takeshima N, Furukawa TA. Maternal exposure to benzodiazepine and risk of preterm birth and low birth weight: a case\u2013control study using a claims database in Japan. Asia Pac Psychiatry. 2018;10:e12309.","journal-title":"Asia Pac Psychiatry."},{"key":"916_CR34","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1111\/j.1447-0756.2010.01512.x","volume":"37","author":"M Hironaka","year":"2011","unstructured":"Hironaka M, Kotani T, Sumigama S, Tsuda H, Mano Y, Hayakawa H, et al. Maternal mental disorders and pregnancy outcomes: a clinical study in a Japanese population. J Obstet Gynaecol Res. 2011;37:1283\u20139.","journal-title":"J Obstet Gynaecol Res."},{"key":"916_CR35","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1111\/1471-0528.14144","volume":"123","author":"AC Eke","year":"2016","unstructured":"Eke AC, Saccone G, Berghella V. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis. BJOG. 2016;123:1900\u20137.","journal-title":"BJOG."},{"key":"916_CR36","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/sj.jp.7211352","volume":"25","author":"KA Lattimore","year":"2005","unstructured":"Lattimore KA, Donn SM, Kaciroti N, Kemper AR, Neal CR, Vazquez DM. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis. J Perinatol. 2005;25:595\u2013604.","journal-title":"J Perinatol."},{"key":"916_CR37","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1001\/jama.2017.3413","volume":"317","author":"AC Sujan","year":"2017","unstructured":"Sujan AC, Rickert ME, \u00d6berg AS, Quinn PD, Hern\u00e1ndez-D\u00edaz S, Almqvist C, et al. Associations of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit\/hyperactivity disorder in offspring. JAMA. 2017;317:1553\u201362.","journal-title":"JAMA"},{"key":"916_CR38","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.schres.2016.07.023","volume":"176","author":"I Petersen","year":"2016","unstructured":"Petersen I, Sammon CJ, McCrea RL, Osborn DPJ, Evans SJ, Cowen PJ, et al. Risks associated with antipsychotic treatment in pregnancy: comparative cohort studies based on electronic health records. Schizophr Res. 2016;176:349\u201356.","journal-title":"Schizophr Res."},{"key":"916_CR39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.schres.2009.10.011","volume":"116","author":"H-C Lin","year":"2010","unstructured":"Lin H-C, Chen I-J, Chen Y-H, Lee H-C, Wu F-J. Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference? Schizophr Res. 2010;116:55\u201360.","journal-title":"Schizophr Res."},{"key":"916_CR40","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/JCP.0b013e318295fe12","volume":"33","author":"F Habermann","year":"2013","unstructured":"Habermann F, Fritzsche J, Fuhlbr\u00fcck F, Wacker E, Allignol A, Weber-Schoendorfer C, et al. Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study. J Clin Psychopharmacol. 2013;33:453\u201362.","journal-title":"J Clin Psychopharmacol."},{"key":"916_CR41","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/jcp.0b013e31815ac4d2","volume":"27","author":"R Lennest\u00e5l","year":"2007","unstructured":"Lennest\u00e5l R, K\u00e4ll\u00e9n B. Delivery outcome in relation to maternal use of some recently introduced antidepressants. J Clin Psychopharmacol. 2007;27:607\u201313.","journal-title":"J Clin Psychopharmacol."},{"key":"916_CR42","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.4088\/JCP.v67n0817","volume":"67","author":"J Djulus","year":"2006","unstructured":"Djulus J, Koren G, Einarson TR, Wilton L, Shakir S, Diav-Citrin O, et al. Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes. J Clin Psychiatry. 2006;67:1280\u20134.","journal-title":"J Clin Psychiatry."},{"key":"916_CR43","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00737-009-0100-7","volume":"12","author":"S Juric","year":"2009","unstructured":"Juric S, Newport DJ, Ritchie JC, Galanti M, Stowe ZN. Zolpidem (Ambien) in pregnancy: placental passage and outcome. Arch Womens Ment Health. 2009;12:441\u20136.","journal-title":"Arch Womens Ment Health."},{"key":"916_CR44","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/clpt.2010.97","volume":"88","author":"L-H Wang","year":"2010","unstructured":"Wang L-H, Lin H-C, Lin C-C, Chen Y-H, Lin H-C. Increased risk of adverse pregnancy outcomes in women receiving zolpidem during pregnancy. Clin Pharmacol Ther. 2010;88:369\u201374.","journal-title":"Clin Pharmacol Ther."},{"key":"916_CR45","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/1471-0528.13114","volume":"122","author":"ET Jensen","year":"2015","unstructured":"Jensen ET, Daniels JL, St\u00fcrmer T, Robinson WR, Williams CJ, Vejrup K, et al. Hormonal contraceptive use before and after conception in relation to preterm birth and small for gestational age: an observational cohort study. BJOG. 2015;122:1349\u201361.","journal-title":"BJOG"},{"issue":"1","key":"916_CR46","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3899\/jrheum.180158","volume":"46","author":"SJ Balevic","year":"2019","unstructured":"Balevic SJ, Cohen-Wolkowiez M, Eudy AM, Green TP, Schanberg LE, Clowse MEB. Hydroxychloroquine levels throughout pregnancies complicated by rheumatic disease: implications for maternal and neonatal outcomes. J Rheumatol. 2019;46(1):57\u201363.","journal-title":"J Rheumatol"},{"key":"916_CR47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0016-5085(98)70628-6","volume":"114","author":"O Diav-Citrin","year":"1998","unstructured":"Diav-Citrin O, Park YH, Veerasuntharam G, Polachek H, Bologa M, Pastuszak A, et al. The safety of mesalamine in human pregnancy: a prospective controlled cohort study. Gastroenterology. 1998;114:23\u20138.","journal-title":"Gastroenterology"},{"key":"916_CR48","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s40263-017-0433-0","volume":"31","author":"G Pariente","year":"2017","unstructured":"Pariente G, Leibson T, Shulman T, Adams-Webber T, Barzilay E, Nulman I. Pregnancy outcomes following in utero exposure to lamotrigine: a systematic review and meta-analysis. CNS Drugs. 2017;31:439\u201350.","journal-title":"CNS Drugs"},{"key":"916_CR49","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.seizure.2015.02.018","volume":"28","author":"I Borthen","year":"2015","unstructured":"Borthen I. Obstetrical complications in women with epilepsy. Seizure. 2015;28:32\u20134.","journal-title":"Seizure"},{"key":"916_CR50","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1111\/epi.12758","volume":"55","author":"D Kilic","year":"2014","unstructured":"Kilic D, Pedersen H, Kjaersgaard MIS, Parner ET, Vestergaard M, S\u00f8rensen MJ, et al. Birth outcomes after prenatal exposure to antiepileptic drugs: a population-based study. Epilepsia. 2014;55:1714\u201321.","journal-title":"Epilepsia"},{"key":"916_CR51","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/ana.25031","volume":"82","author":"S Hern\u00e1ndez-D\u00edaz","year":"2017","unstructured":"Hern\u00e1ndez-D\u00edaz S, McElrath TF, Pennell PB, Hauser WA, Yerby M, Holmes LB, et al. Fetal growth and premature delivery in pregnant women on antiepileptic drugs. Ann Neurol. 2017;82:457\u201365.","journal-title":"Ann Neurol"},{"key":"916_CR52","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1055\/s-0035-1554626","volume":"220","author":"K Gharehbaghi","year":"2016","unstructured":"Gharehbaghi K, Gharehbaghi DR, Wierrani F. Sliutz G [Treatment of chronic functional constipation during pregnancy and lactation]. Z Geburtshilfe Neonatol. 2016;220:9\u201315.","journal-title":"Z Geburtshilfe Neonatol"},{"key":"916_CR53","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.gyobfe.2011.07.044","volume":"39","author":"C Hurault-Delarue","year":"2011","unstructured":"Hurault-Delarue C, Lacroix I, Vidal S, Montastruc J-L, Damase-Michel C. Drugs in pregnancy: study in the EFEMERIS database (2004 to 2008). Gynecol Obstet Fertil. 2011;39:554\u20138.","journal-title":"Gynecol Obstet Fertil"},{"key":"916_CR54","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s40264-015-0302-z","volume":"3","author":"L de Jonge","year":"2015","unstructured":"de Jonge L, de Walle HEK, de Jong-van den Berg LTW, van Langen IM, Bakker MK. Actual use of medications prescribed during pregnancy: a cross-sectional study using data from a population-based congenital anomaly registry. Drug Saf. 2015;3:737\u201347.","journal-title":"Drug Saf"},{"key":"916_CR55","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11096-014-0044-5","volume":"37","author":"VK Patadia","year":"2015","unstructured":"Patadia VK, Schuemie MJ, Coloma P, Herings R, van der Lei J, Straus S, et al. Evaluating performance of electronic healthcare records and spontaneous reporting data in drug safety signal detection. Int J Clin Pharm. 2015;37:94\u2013104.","journal-title":"Int J Clin Pharm."},{"key":"916_CR56","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s40264-015-0341-5","volume":"38","author":"AC Pacurariu","year":"2015","unstructured":"Pacurariu AC, Straus SM, Trifir\u00f2 G, Schuemie MJ, Gini R, Herings R, et al. Useful interplay between spontaneous ADR reports and electronic healthcare records in signal detection. Drug Saf. 2015;38:1201\u201310.","journal-title":"Drug Saf."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-020-00916-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-020-00916-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-020-00916-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T12:39:18Z","timestamp":1722515958000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-020-00916-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,2]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["916"],"URL":"https:\/\/doi.org\/10.1007\/s40264-020-00916-5","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,2]]},"assertion":[{"value":"2 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This research was partially supported by the IReSP funding partners as part of the 2017 General Call for Projects-Prevention (17-PREV-49) and partially supported by the ANSM (Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9) as part of the 2014 \u2018young researchers\u2019 Call for Projects (AAP-2014-033).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Romain Demailly, Sylvie Escolano, Fran\u00e7oise Haramburu, Pascale Tubert-Bitter, and Isma\u00efl Ahmed have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}